Laddar...
Tolvaptan- and Tolvaptan-Metabolite-Responsive T Cells in Patients with Drug-Induced Liver Injury
[Image: see text] Tolvaptan is an effective drug for the treatment of autosomal dominant polycystic kidney disease, but its use is associated with a significant risk of liver injury in a small number of patients. Herein we describe the presence of tolvaptan- and tolvaptan-metabolite-responsive T cel...
Sparad:
| I publikationen: | Chem Res Toxicol |
|---|---|
| Huvudupphovsmän: | , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
American Chemical
Society
2020
|
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7672698/ https://ncbi.nlm.nih.gov/pubmed/33085478 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acs.chemrestox.0c00328 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|